Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Antimicrobial Agents and Chemotherapy|March 1, 1996
Susceptibilities of non-Pseudomonas aeruginosa gram-negative nonfermentative rods to ciprofloxacin, ofloxacin, levofloxacin, D-ofloxacin, sparfloxacin, ceftazidime, piperacillin, piperacillin-tazobactam, trimethoprim-sulfamethoxazole, and imipenemS K Spangler, M A Visalli, M R Jacobs, et al.
Antimicrobial Agents and Chemotherapy|August 1, 1996
Comparative activities of clarithromycin, erythromycin, and azithromycin against penicillin-susceptible and penicillin-resistant pneumococciL M Ednie, M A Visalli, M R Jacobs, et al.
Journal of Virology|July 24, 2015
Intermolecular Complementation between Two Varicella-Zoster Virus pORF30 Terminase Domains Essential for DNA EncapsidationMelissa A Visalli, Brittany L House, Frances J Lahrman, et al.
Virus Genes|December 5, 2006
Characterization of the murine cytomegalovirus m136 geneRobert J Visalli, Denise M Nicolosi, Karen Irven, et al.
Journal of Virology|May 9, 2014
The varicella-zoster virus portal protein is essential for cleavage and packaging of viral DNAMelissa A Visalli, Brittany L House, Anca Selariu, et al.
Viruses|November 27, 2025
Small Molecule Compounds Inhibit Varicella-Zoster Virus Replication by Targeting the Portal Protein-Capsid InterfaceJulius Svensmark, Emily Polk, Ellyn Kornfeind, et al.
Antimicrobial Agents and Chemotherapy|February 27, 2003
Efflux-mediated resistance to tigecycline (GAR-936) in Pseudomonas aeruginosa PAO1Charles R Dean, Melissa A Visalli, Steven J Projan, et al.
Virus Research|April 6, 2012
The Varicella-zoster virus ORF54 gene product encodes the capsid portal protein, pORF54Alexander J Howard, Debra M Sherman, Melissa A Visalli, et al.
Antimicrobial Agents and Chemotherapy|April 1, 1997
Activities of beta-lactams against Acinetobacter genospecies as determined by agar dilution and E-test MIC methodsM A Visalli, M R Jacobs, T D Moore, et al.
Antimicrobial Agents and Chemotherapy|December 17, 2008
Pyrosequencing using the single-nucleotide polymorphism protocol for rapid determination of TEM- and SHV-type extended-spectrum beta-lactamases in clinical isolates and identification of the novel beta-lactamase genes blaSHV-48, blaSHV-105, and blaTEM-155C Hal Jones, Alexey Ruzin, Margareta Tuckman, et al.
Pageof 4